Overview

Safety and Efficacy of Inhaled Treprostinil in Patients With PAH

Status:
Withdrawn
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
To evaluate the effect of inhaled treprostinil compared to placebo on exercise capacity and time to clinical worsening.
Phase:
Phase 3
Details
Lead Sponsor:
United Therapeutics
Treatments:
Treprostinil